Fall outs for STK5: Antithrombotic Therapy Administered by End of Hospital Day 2

XMLWordPrintable

    • Type: Hosp Inpt eCQMs - Hospital Inpatient eCQMs
    • Resolution: Answered
    • Priority: Moderate
    • Component/s: None
    • None
    • Beth Rhoads
    • 6109144366
    • Penn State Health
    • Hide
      Thank you for your question regarding CMS72 STK-5 eCQM. Tenecteplase 25mg was not an available medication RXNORM term type during the during the last annual update. We have reviewed the code with our SME and will be adding this code to the VS during our annual update process. We appreciate your feedback regarding the measures and terminologies.
      Show
      Thank you for your question regarding CMS72 STK-5 eCQM. Tenecteplase 25mg was not an available medication RXNORM term type during the during the last annual update. We have reviewed the code with our SME and will be adding this code to the VS during our annual update process. We appreciate your feedback regarding the measures and terminologies.
    • CMS0072v14
    • Hide
      Patients not being excluded from the denominator due to new RxNorm code for the 25 mg vial of Tenecteplase not being included as thrombolytic therapy given during hospitalization. Our organization is being penalized for providing the recommended care to our patients.
      Show
      Patients not being excluded from the denominator due to new RxNorm code for the 25 mg vial of Tenecteplase not being included as thrombolytic therapy given during hospitalization. Our organization is being penalized for providing the recommended care to our patients.

      [Desired action conserved from the Solution field: Add RxNorm code for Tenecteplase 25mg to better capture the intervention.]

       

      To whom it may concern,

      On behalf of our eCQM team, would like to respectfully request the inclusion of the RxNorm code for the newly available Tenecteplase 25 mg vial in the value set with OID 2.16.840.1.113883.3.117.1.7.1.226.

      • Clinical rationale:
      • Tenecteplase is now available in a 25 mg vial, which aligns with the maximum recommended dosage for ischemic stroke.
      • Previously, only 50-100 mg vials were available, which posed a risk of inadvertent overdosing if the entire vial was administered.
      • The 25 mg vial was introduced specifically to improve patient safety and reduce dosing errors in ischemic stroke patients.
      • Measure impact:
      • Because the RxNorm code for the 25 mg vial is not currently included in the value set, patients who received this safer dose are not being correctly excluded from the denominator.
      • This results in inaccurate measure reporting and penalizes organizations for adopting safer practices.

      Request:

      1. Please consider adding the RxNorm code for the Tenecteplase 25 mg vial to the value set.

            Assignee:
            Mathematica EH eCQM Team
            Reporter:
            Beth Rhoads
            Votes:
            0 Vote for this issue
            Watchers:
            3 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On: